1. Home
  2. BOC vs ENTA Comparison

BOC vs ENTA Comparison

Compare BOC & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Omaha Corporation

BOC

Boston Omaha Corporation

HOLD

Current Price

$12.53

Market Cap

413.9M

Sector

N/A

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$15.44

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOC
ENTA
Founded
2009
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.9M
407.5M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
BOC
ENTA
Price
$12.53
$15.44
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$25.00
$20.40
AVG Volume (30 Days)
190.5K
304.7K
Earning Date
11-13-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$112,601,970.00
$65,324,000.00
Revenue This Year
$6.29
$0.99
Revenue Next Year
$5.09
$0.19
P/E Ratio
N/A
N/A
Revenue Growth
7.22
N/A
52 Week Low
$11.30
$4.09
52 Week High
$15.75
$15.34

Technical Indicators

Market Signals
Indicator
BOC
ENTA
Relative Strength Index (RSI) 39.57 68.21
Support Level $13.41 $14.07
Resistance Level $13.83 $15.28
Average True Range (ATR) 0.36 0.81
MACD -0.02 -0.03
Stochastic Oscillator 2.26 79.86

Price Performance

Historical Comparison
BOC
ENTA

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: